NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Aker ASA ( AKAAF) Q4 2025 Earnings Call February 13, 2026 3:00 AM EST ...
Amgen (NASDAQ:AMGN) today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to ...
This report brings new evidence on how human capital is formed, showing that homes, neighborhoods, and workplaces play a ...
Impax Global Sustainable Infrastructure Fund reviews Q4 2025 performance and infrastructure trends. Analyze the impact of AI disruption on your portfolio now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results